Cardlytics, Inc.(CDLX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,727 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CDLX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Cardlytics, Inc. (CDLX), a Technology sector company. 13F Pro's AI-powered ranking engine scores CDLX at 16.8/100 on a 32-signal composite quality model, placing it at rank #2,727 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (6.3) and revenue growth (9.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Cardlytics, Inc. reports quarterly revenue of $34.3M, net income of $-4.5M, free cash flow of $-5.7M. Top institutional holders of CDLX by reported 13-F value include PenderFund Capital Management Ltd., Context Capital Management,, FMR, based on the most recent SEC filings. CDLX trades on the Nasdaq exchange and files with the SEC under CIK 1666071. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CDLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardlytics, Inc. directly from SEC EDGAR. Cardlytics, Inc.'s 13F Pro composite quality score has ranged between 8 and 40 since 2021, currently 16.8 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$34.3M
Net Income
Q1 2026
$-4.5M
Free Cash Flow
Q1 2026
$-5.7M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-24.6% YoYNet Income
+23.3% YoYOperating Income
+25.0% YoYEPS (Diluted)
+47.2% YoYTotal Assets
-50.2% YoYTotal Debt
-17.4% YoYOp. Cash Flow
+5121.6% YoY| Metric | FY 2025 | FY 2023 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $233.3M -24.6% | $309.2M +46.9% | $210.4M +39.6% | $150.7M +15.6% | $130.4M +15.6% | $112.8M |
| Net Income | $-103.5M +23.3% | $-135.0M -687.4% | $-17.1M +67.7% | $-53.0M -170.1% | $-19.6M +74.1% | $-75.7M |
| Operating Income | $-101.8M +25.0% | $-135.7M -683.1% | $-17.3M +57.7% | $-40.9M -139.3% | $-17.1M +69.6% | $-56.2M |
| EPS (Diluted) | $-1.95 +47.2% | $-3.69 | — | — | — | — |
| Total Assets | $285.6M -50.2% | $574.1M +156.0% | $224.3M +45.9% | $153.8M +52.6% | $100.8M | — |
| Total Debt | $212.6M -17.4% | $257.5M +695856.8% | $37.0K -99.9% | $46.7M -18.1% | $57.1M | — |
| Operating Cash Flow | $9.3M +5121.6% | $-185.0K -101.6% | $11.5M +160.3% | $-19.0M +14.1% | $-22.1M +32.0% | $-32.5M |
Get alerted when CDLX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Cardlytics, Inc. including:
Top Institutional Holders of CDLX
PenderFund Capital Management Ltd.
$13.5M47,710,000 shContext Capital Management, LLC
$9.2M26,290,000 shFMR LLC
$8.5M31,141,000 shCAS Investment Partners, LLC
$5.5M5,198,067 sh683 Capital Management, LLC
$4.2M15,500,000 shWOLVERINE ASSET MANAGEMENT LLC
$3.7M12,379,000 shCAPSTONE INVESTMENT ADVISORS, LLC
$3.2M11,145,000 shVANGUARD CAPITAL MANAGEMENT LLC
$2.2M2,063,367 sh683 Capital Management, LLC
$1.5M1,450,000 shKPS Global Asset Management UK Ltd
$1.3M1,218,830 sh
| Fund | Value | Shares |
|---|---|---|
| PenderFund Capital Management Ltd. | $13.5M | 47,710,000 |
| Context Capital Management, LLC | $9.2M | 26,290,000 |
| FMR LLC | $8.5M | 31,141,000 |
| CAS Investment Partners, LLC | $5.5M | 5,198,067 |
| 683 Capital Management, LLC | $4.2M | 15,500,000 |
| WOLVERINE ASSET MANAGEMENT LLC | $3.7M | 12,379,000 |
| CAPSTONE INVESTMENT ADVISORS, LLC | $3.2M | 11,145,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.2M | 2,063,367 |
| 683 Capital Management, LLC | $1.5M | 1,450,000 |
| KPS Global Asset Management UK Ltd | $1.3M | 1,218,830 |
More Technology Companies
View all Technology →Put CDLX on your watchlist
Track score changes the day Cardlytics, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CDLX a good stock to buy?
13F Pro's AI-powered analysis of Cardlytics, Inc. (CDLX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CDLX are available on the CDLX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CDLX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CDLX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cardlytics, Inc.'s investment landscape.